Hoth Therapeutics stock shifts toward drones after 100 percent deal
Published on 10/01/2026 at 06:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Hoth Therapeutics stock is now tied to Rocket One's planned 100 percent acquisition of Tracer Drone Technologies, a move that shifts the former biotechnology company toward drones and artificial intelligence. The transaction was disclosed in a SEC filing dated September 22, 2026.
Tracer expands the new strategy
Rocket One executed the membership interest purchase agreement on September 18, 2026, according to StockTitan. The deal covers 100 percent of Tracer, which provides drone hardware, software, training, maintenance and managed services.
Tracer is already revenue-generating and is expected to operate as a wholly owned subsidiary after closing, subject to customary conditions. That operating base gives Rocket One a commercial platform alongside its Swarm Stage AI technology and legacy biotechnology assets.
Revenue is the key test
The contrast is stark: the acquisition covers 100 percent of a revenue-generating target, while Rocket One reported USD 0 revenue and a USD 6.5 million net loss for the six months ended June 30, 2026, according to StockTitan. The transaction therefore adds an operating business to a company whose reported period still showed substantial losses and zero revenue.
Market value stays in microcap territory
A finance snapshot dated August 5, 2026 put Rocket One's market capitalization at USD 10.6 million. The size of that valuation makes the Tracer transaction material to the company's operating profile, but the acquisition remains subject to closing conditions rather than completed revenue consolidation.
Rocket One replaces the Hoth name
Rocket One became the company's legal name on May 26, 2026, and the common stock moved from HOTH to RKTO on Nasdaq on May 28, 2026, according to the StockTitan filing summary. The legacy biotechnology programs continue through a wholly owned subsidiary, while the parent company emphasizes space, defense and AI infrastructure.
Hoth Therapeutics company snapshot
- Company: Rocket One Inc.
- Ticker: RKTO
- Primary exchange: Nasdaq Stock Market
- Market capitalization: USD 10.6 million (as of August 5, 2026)
- Former ticker: HOTH
